SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-09-007888
Filing Date
2009-02-13
Accepted
2009-02-13 12:47:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v139626_sc13ga.htm SC 13G/A 95452
  Complete submission text file 0001144204-09-007888.txt   97329
Mailing Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83793 | Film No.: 09600681
SIC: 2834 Pharmaceutical Preparations

Mailing Address TRANSDEL PHARMACEUTICALS, INC. 4225 EXECUTIVE SQUARE, SUITE 460 LA JOLLA CA 92037
Business Address (858) 457-5300
Singh Juliet (Filed by) CIK: 0001421383 (see all company filings)

Type: SC 13G/A